OncoCyte Corporation ( OCX) - Key Metrics
Stock symbol OCX is outdated, potentially delisted? Maybe it is available on other exchange?
OCX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $0.08 | -$0.26 | -$0.23 | -$0.23 |
| 2024Q4 | $0.11 | -$2.56 | -$0.41 | -$0.43 |
| 2024Q3 | $0.01 | -$0.98 | -$0.40 | -$0.39 |
| 2024Q2 | $0.01 | -$0.35 | -$0.46 | -$0.48 |
| 2024Q1 | $0.02 | -$1.10 | -$0.46 | -$0.47 |
OCX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -2.95 |
| 2024Q4 | ? | -0.23 |
| 2024Q3 | ? | -0.72 |
| 2024Q2 | ? | -2.10 |
| 2024Q1 | ? | -0.67 |
OCX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q1 | -7.45% | ? |
| 2024Q4 | -17.90% | ? |
| 2024Q3 | -13.65% | ? |
| 2024Q2 | -16.25% | ? |
| 2024Q1 | -15.65% | ? |
OCX
Price: $3.20
52 week price:
Earnings Per Share: -3.79 USD
P/E Ratio: -0.81
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 412400
Market Capitalization: 87.8 million